331 related articles for article (PubMed ID: 21641700)
1. Synthesis and biological evaluation of 1-(4'-Indolyl and 6'-Quinolinyl) indoles as a new class of potent anticancer agents.
Lai MJ; Chang JY; Lee HY; Kuo CC; Lin MH; Hsieh HP; Chang CY; Wu JS; Wu SY; Shey KS; Liou JP
Eur J Med Chem; 2011 Sep; 46(9):3623-9. PubMed ID: 21641700
[TBL] [Abstract][Full Text] [Related]
2. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular docking study and antitumor activity of novel 2-phenylindole derivatives.
El-Nakkady SS; Hanna MM; Roaiah HM; Ghannam IA
Eur J Med Chem; 2012 Jan; 47(1):387-98. PubMed ID: 22119129
[TBL] [Abstract][Full Text] [Related]
4. Arylthioindoles, potent inhibitors of tubulin polymerization.
De Martino G; La Regina G; Coluccia A; Edler MC; Barbera MC; Brancale A; Wilcox E; Hamel E; Artico M; Silvestri R
J Med Chem; 2004 Dec; 47(25):6120-3. PubMed ID: 15566282
[TBL] [Abstract][Full Text] [Related]
5. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
[TBL] [Abstract][Full Text] [Related]
6. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
Kumar D; Sundaree S; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents.
Lai MJ; Kuo CC; Yeh TK; Hsieh HP; Chen LT; Pan WY; Hsu KY; Chang JY; Liou JP
ChemMedChem; 2009 Apr; 4(4):588-93. PubMed ID: 19266513
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents.
Kumar D; Narayanam MK; Chang KH; Shah K
Chem Biol Drug Des; 2011 Mar; 77(3):182-8. PubMed ID: 21251232
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
10. 2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors.
Chuang HY; Chang JY; Lai MJ; Kuo CC; Lee HY; Hsieh HP; Chen YJ; Chen LT; Pan WY; Liou JP
ChemMedChem; 2011 Mar; 6(3):450-6. PubMed ID: 21360819
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Kumar D; Maruthi Kumar N; Chang KH; Shah K
Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors.
Liou JP; Wu ZY; Kuo CC; Chang CY; Lu PY; Chen CM; Hsieh HP; Chang JY
J Med Chem; 2008 Jul; 51(14):4351-5. PubMed ID: 18588280
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents.
Li WT; Hwang DR; Chen CP; Shen CW; Huang CL; Chen TW; Lin CH; Chang YL; Chang YY; Lo YK; Tseng HY; Lin CC; Song JS; Chen HC; Chen SJ; Wu SH; Chen CT
J Med Chem; 2003 Apr; 46(9):1706-15. PubMed ID: 12699388
[TBL] [Abstract][Full Text] [Related]
15. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Nov; 49(23):6656-9. PubMed ID: 17154496
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents.
Zhang HJ; Qian Y; Zhu DD; Yang XG; Zhu HL
Eur J Med Chem; 2011 Sep; 46(9):4702-8. PubMed ID: 21816517
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of derivatives of 4-deoxypodophyllotoxin as antitumor agents.
Jin Y; Liu J; Huang WT; Chen SW; Hui L
Eur J Med Chem; 2011 Sep; 46(9):4056-61. PubMed ID: 21733601
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-tumor activities of a novel series of tricyclic 1-anilino-5H-pyridazino[4,5-b]indoles.
Li RD; Zhai X; Zhao YF; Yu S; Gong P
Arch Pharm (Weinheim); 2007 Aug; 340(8):424-8. PubMed ID: 17628035
[TBL] [Abstract][Full Text] [Related]
19. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
[TBL] [Abstract][Full Text] [Related]
20. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
